Role of health technology assessment in pharmaceutical market access in developed countries

Kahveci, Rabia and Oortwijn, Wija and Godman, Brian and Meltem Koç, E. and Tibet, Birol (2018) Role of health technology assessment in pharmaceutical market access in developed countries. In: Pharmaceutical Market Access in Developed Markets. SEEd Medical Publishers, Italy, pp. 225-256. ISBN 8897419739

[img]
Preview
 Text (Kahveci-etal-SEEd-2017-Role-of-health-technology-assessment-in-pharmaceutical)
Kahveci_etal_SEEd_2017_Role_of_health_technology_assessment_in_pharmaceutical.pdf
Final Published Version
Download (780kB)| Preview

    Abstract

    Introduction and use of a health technology in a health care setting has clinical, economic, as well as organizational, social-cultural, legal and ethical impacts. Health Technology Assessment (HTA) is a multidisciplinary field that addresses these impacts, considering healthcare context as well as available alternatives. HTA mainly aims to inform policy and clinical decision making. While systematically evaluating the effects of the health technology, HTA addresses direct and intended effects as well as the indirect and unintended effects. It is a multidisciplinary field with well-developed systematic processes and methods

    Author(s):Kahveci, Rabia, Oortwijn, Wija, Godman, Brian, Meltem Koç, E. and Tibet, Birol
    Item type:Book Section
    ID code:61921
    Keywords:health technology, pharmaceutical markets, developing countries, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all)
    Subjects:Medicine > Pharmacy and materia medica
    Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
    Depositing user: Pure Administrator
    Date deposited:03 Oct 2017 15:40
    Last modified:18 Oct 2019 07:45
    Related URLs:
    URI:https://strathprints.strath.ac.uk/id/eprint/61921
    Export data:
    CORE (COnnecting REpositories)